AzTrials
AzTrials

Hot FlashesPhase 1NCT00317304

Mindfulness Based Stress Reduction for Hot Flashes

A Phase 1 study testing Mindfulness-based stress reduction in people with Hot Flashes and Stress, run by University of Massachusetts, Worcester at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Stress appears to be related to hot flash frequency and intensity, and the degree of distress that women experience from their hot flashes appears to be related to their coping resources. Read more about this study

Who is it for?
Ages 40 to 69 years, women onlyHealthy volunteers can take part
Conditions the study is for
Hot Flashes, Stress
What is being tested?
Mindfulness-based stress reduction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteUnited States
Study dates
Jan 2005to Aug 2012
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 69 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Average of 5+ hot flashes per day
  • No menses in prior 3 months
  • Ages between 40 and 69 years
  • English speaking
  • Access to a telephone
  • Availability for the entire study period
Show all 9Show fewer
  • Agree to maintain usual diet
  • Agree to maintain usual exercise habits
  • Consent to the study

Who cannot join

  • Psychiatric illness
  • Illness with less than one year life expectancy
  • Alcohol use ≥ 2 drinks per day
  • Current substance abuse or addiction
  • Use of selective estrogen receptor modulator (SERM) medications within the past 3 months
  • Use of HT within the past 3 months
  • Currently pregnant or breastfeeding
  • Ongoing mindfulness meditation practice

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Massachusetts Medical School

    Worcester, Massachusetts, 01655

Other trials in United States

About this study

Stress appears to be related to hot flash frequency and intensity, and the degree of distress that women experience from their hot flashes appears to be related to their coping resources. This trial is a pilot study to test the effect of participation in a mindfulness-based stress reduction program on hot flash frequency and intensity, as well as menopause-related quality of life.

Read the detailed description

The majority of women experience vasomotor symptoms (VMS) such as hot flashes (HF) and night sweats as they transition through menopause, and a substantial minority experience considerable distress and diminished role functioning. Until recently most women found relief through hormone therapy (HT), but concern about the health risks associated with HT has left women with few effective and safe choices for relief from their symptoms other than their own coping strategies. A variety of results from both population and laboratory studies suggest that stress and HF are correlated and that HF are more severe in women with lower coping abilities, but evidence is far from conclusive. Consequently, investigators have called for trials to evaluate the effect of stress reduction interventions on HF. Mindfulness-Based Stress Reduction (MBSR) is a widely available manualized program shown to be an effective adjunctive intervention in reducing medical symptoms and psychological distress for a wide range of stress-related disorders. In a small preliminary study using MBSR we found reductions in HF severity scores and increases in menopause-related quality of life (QOL). This R21 proposal is for a pilot randomized trial of MBSR compared to a wait-list control group for 120 menopausal women experiencing seven or more HF/day of moderate to severe intensity. It aims to:

  1. assess feasibility of recruitment, adherence to program intervention, and compliance with assessment instruments in preparation for a larger RCT; and
  2. provide preliminary estimates of efficacy of the effects of MBSR in reducing self-reported HF frequency and intensity and improving QOL.

In addition, we will use sternal skin conductance as an established objective measure of VMS in a subgroup of 15 women in each arm to test feasibility and obtain information on how objectively measured HF are related to self-reported HF in this setting. Women will be assessed at baseline, at the end of the eight-week MBSR course, and at three months after the end of the course. A secondary aim is to explore whether treatment group differences of HF frequency and intensity and QOL are explained by changes in perceived stress, health-related locus of control and mindfulness. It is anticipated that results from this pilot study will provide data needed to plan a larger more definitive randomized trial on the effect of MBSR on HF frequency and intensity and on the ability to cope with these symptoms.

Conditions
Hot Flashes, Stress
Being tested
Mindfulness-based stress reduction
Keywords
Hot flashes, vasomotor symptoms, menopause, mindfulness based stress reduction, meditation
Medical subject headings
Hot Flashes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-based stress reductionBehavioural

    Also called MBSR

    MBSR is an 8-week group-based program of training in mindfulness and its application to the stresses and challenges of everyday life

Study groups in NCT00317304
Study groupRoleWhat they receive
MBSRExperimentalNot described
Receives: Behavioral: Mindfulness-based stress reduction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hot flash frequency and intensity

    Measured: Baseline, 8 weeks, 24 weeks

Secondary outcomes (9)
  1. Menopause-related quality of life

    Measured: Baseline, 8 weeks, 24 weeks

  2. Hot Flash-Related Daily Interference Scale

    Measured: Baseline, 8 weeks, 24 weeks

  3. Women's Health Initiative (WHI) Insomnia Rating Scale

    Measured: Baseline, 8 weeks, 24 weeks

  4. 5 factor of Mindfulness questionnaire

    Measured: Baseline, 8 weeks, 24 weeks

  5. Health locus of control

    Measured: Baseline, 8 weeks, 24 weeks

  6. Perceived stress

    Measured: Baseline, 8 weeks, 24 weeks

  7. Dietary intake

    Measured: Baseline, 8 weeks, 24 weeks

  8. Compliance with intervention conditions

    Measured: Baseline, 8 weeks, 24 weeks

  9. HADS

    Measured: Baseline, 8 weeks, 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2006 (estimated)
  2. Study startJan 2005
  3. Primary completionAug 2012
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00317304
Sponsor's protocol ID
R21AT002910-01
Other IDs
R21AT002910-01
Status last verified
Oct 2012
First submitted
20 Apr 2006
Last updated
4 Oct 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause. 2011 Jun;18(6):611-20. doi: 10.1097/gme.0b013e318204a05c.

    PubMed 21372745

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Mindfulness-based stress reduction in people with Hot Flashes and Stress, run by University of Massachusetts, Worcester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hot flash frequency and intensity (time frame: Baseline, 8 weeks, 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00317304, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in